2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide
-
![2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/c8c9adeb6dfc4e9cba85fd45a8990f02.png "2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide")
2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide
structure -
-
CAS No:
111728-01-9
-
Formula:
C21H28N2OS
-
Chemical Name:
2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide
-
Synonyms:
benzo(b)thiophene-4-acetamide, N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-(+-)-;N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzo(b)thiophene-acetamide;PD 117302;PD-117302;PD117302;RSD 921;RSD-921;trans-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl-)benzo-(b)-thiophene-4-acetamide;RSD-921;PD 117302;PD-117302;111728-01-9;UNII-T1I84BQJ6E;114419-77-1;T1I84BQJ6E;2-(benzo[b]thiophen-4-yl)-N-methyl-N-((1R,2R)-2-(pyrrolidin-1-yl)cyclohexyl)acetamide;2-(Benzothiophen-4-yl)-N-methyl-N-((1R,2R)-2-pyrrolidin-1-ylcyclohexyl)acetamide;RSD 921;trans-N-Methyl-N-(2-(1-pyrrolidinyl)cyclohexyl-)benzo-(b)-thiophene-4-acetamide;PD-123497;Benzo(b)thiophene-4-acetamide, N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-(+-)-;SCHEMBL5674183;CHEMBL1193536;DTXSID30920560;N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzo(b)thiophene-acetamide;(+)-2-(Benzothiophen-4-yl)-N-methyl-N-((1R,2R)-2-pyrrolidin-1-ylcyclohexyl)acetamide;2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide;(+)-PD-123497;UNII-J324VS633R component SYHJZCCNQDFHJQ-RTBURBONSA-N;2-(1-BENZOTHIOPHEN-4-YL)-N-METHYL-N-[2-(PYRROLIDIN-1-YL)CYCLOHEXYL]ACETAMIDE
-
CAS No:
2-(1-benzothiophen-4-yl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide Basic Attributes
356.5 g/mol
356.19223469 g/mol
T1I84BQJ6E
Drug Information
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
benzo(b)thiophene-4-acetamide, N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-(+-)-
Computed Properties
Molecular Weight:356.5
XLogP3:4.2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:4
Exact Mass:356.19223469
Monoisotopic Mass:356.19223469
Topological Polar Surface Area:51.8
Heavy Atom Count:25
Complexity:465
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation